Company Quick10K Filing
1847 Holdings
S-1 2020-10-30 Public Filing
10-Q 2020-09-30 Filed 2020-11-23
10-Q 2020-06-30 Filed 2020-08-14
10-Q 2020-03-31 Filed 2020-05-15
S-1 2020-01-23 Public Filing
10-K 2019-12-31 Filed 2020-03-30
10-Q 2019-09-30 Filed 2019-11-19
10-Q 2019-06-30 Filed 2019-08-19
10-Q 2019-03-31 Filed 2019-05-15
10-K 2018-12-31 Filed 2019-04-15
10-Q 2018-09-30 Filed 2018-11-19
10-Q 2018-06-30 Filed 2018-08-17
10-Q 2018-03-31 Filed 2018-05-21
10-K 2017-12-31 Filed 2018-04-17
10-Q 2017-09-30 Filed 2017-11-14
10-Q 2017-06-30 Filed 2017-08-21
10-Q 2017-03-31 Filed 2017-05-22
10-K 2016-12-31 Filed 2017-04-17
10-Q 2016-09-30 Filed 2016-11-21
10-Q 2016-06-30 Filed 2016-08-22
10-Q 2016-03-31 Filed 2016-05-16
10-K 2015-12-31 Filed 2016-04-14
10-Q 2015-09-30 Filed 2015-11-23
10-Q 2015-06-30 Filed 2015-08-19
10-Q 2015-03-31 Filed 2015-05-15
10-K 2014-12-31 Filed 2015-04-15
10-Q 2014-09-30 Filed 2014-11-14
10-Q 2014-06-30 Filed 2014-08-19
10-Q 2014-03-31 Filed 2014-06-23
8-K 2021-02-09 Enter Agreement
8-K 2021-01-14 Officers, Exhibits
8-K 2020-12-22 Enter Agreement
8-K 2020-12-07 Enter Agreement, Off-BS Arrangement, Exhibits
8-K 2020-11-20 Enter Agreement, Exhibits
8-K 2020-10-26
8-K 2020-10-23
8-K 2020-10-20
8-K 2020-10-20
8-K 2020-09-30
8-K 2020-09-25
8-K 2020-08-28
8-K 2020-08-27
8-K 2020-08-25
8-K 2020-07-30
8-K 2020-07-29
8-K 2020-07-17
8-K 2020-05-28
8-K 2020-05-11
8-K 2020-03-27
8-K 2019-09-24
8-K 2019-07-12
8-K 2019-07-10
8-K 2019-05-31
8-K 2019-04-05
8-K 2019-03-13
8-K 2019-01-18
8-K 2018-11-12
8-K 2018-06-13
8-K 2018-05-10
8-K 2018-04-18
8-K 2018-01-19
8-K 2018-01-03

1847 Holdings Financials

EFSH Metrics, Comps, Filings

Quarterly | Annual

Valuation ($MM)

Market Cap, Enterprise Value

Balance Sheet ($MM)

Assets, Equity

Income Statement ($MM Quarterly)

Revenue, G Profit, Net Income

Cash Flow ($MM Quarterly)

Ops, Inv, Fin

Comps ($'000 TTM) Market Cap Gross Margin EV/EBITDA Ret on Assets Assets Liabilities Revenue G Profit Net Income EBITDA EV
20 20 Global (TWGL)
024 Pharma (EEIG)
111 (YI) 0% 1,546,418 322,654 0 0 0 0 -853,740
1 800 Flowers Com (FLWS) 944,324 42% 13.3 6% 664,955 335,559 1,266,390 533,727 36,761 75,090 1,000,932
10x Genomics (TXG) 4,804,979 75% -490.3 -2% 572,815 151,367 61,207 45,727 -9,603 -8,887 4,357,180
12 Retech (RETC) 0 32% -0.1 -1,385% 1,118 20,421 625 199 -15,491 -14,800 966
11 Good Energy (ELVN)
1347 Property Insurance Holdings (PIH) 33,711 0% 0.4 -5% 164,088 108,405 18,194 0 -7,969 -8,017 -2,855
1347 Capital Corp (TFSC)
180 Degree Capital (TURN)
1847 Holdings (EFSH) 25% -2.4 -15% 18,527 23,194 27,219 6,699 -2,862 -1,433 3,396
1895 Bancorp of Wisconsin (BCOW) 46,152,715 12,508.1 -0% 441,187 382,722 0 0 -44 3,689 46,142,359
1st Constitution Bancorp (FCCY) 164,504 0% 4.4 1% 1,342,565 1,204,038 490 0 13,787 32,503 143,748
1st Franklin Financial (FFC) 3,551 -0.6 7% 905,107 644,730 0 0 62,078 80,004 -45,962
24 7 Kid Doc (TVMD)
1st Source (SRCE) 1,200,033 7.9 1% 6,691,070 5,858,028 0 0 70,061 136,342 1,072,548
2050 Motors (ETFM) 0 -0.2 -166,272,400% 0 1,849 0 0 -1,663 -1,654 250
21Vianet Group (VNET) 6,005,116 0% 11,150,717 5,787,533 0 0 0 0 3,344,095
22nd Century (XXII) 301,854 1% -14.1 -36% 61,864 6,554 25,706 304 -22,433 -21,464 301,826
1Life Healthcare (ONEM)

Balance Sheet ($'000)2014-03-312014-06-302014-09-302014-12-312015-03-312015-06-302015-09-302015-12-312016-03-312016-06-302016-09-302016-12-312017-06-302017-09-302017-12-312018-03-312018-06-302018-09-302018-12-312019-06-302019-09-30
Cash013000000000016928750178989334318197
Accounts Receivable2538506275881001001001001000300261310942992455502,5881,790
Inventory05625668377717478584882,6882,571
PP&E6,5397,4297,2137,1286,9546,9546,9317,1297,132
Assets405157637511310110110110010008,0677,9048,0846,9496,5956,3556,05219,46918,527
Accounts Payable
Long-Term Debt4,38132458553,5033,2973,2623,8223,593
Liabilities531281482523053854545015405846286707,1709,6548,5708,2288,2988,4858,07922,95723,194
Stockholders' Equity-13-77-91-189-230-272-353-400-439-484-528-6701,287-1,202-485-1,278-1,703-2,130-2,027-3,488-4,668
Income Statement ($'000)2014-03-312014-06-302014-09-302014-12-312015-03-312015-06-302015-09-302015-12-312016-03-312016-06-302016-09-302016-12-312017-06-302017-09-302017-12-312018-03-312018-06-302018-09-302018-12-312019-06-302019-09-30
Revenue44444444444444000001,7881,2052,7567631,4701,46712,20813,544
Cost of Revenue-1811,5531,5634789,33210,710
Gross Profit181235-3589882,8762,835
R&D
SG&A4444454545454622221028036955065353752811,7111,964
Tax0000000000000-407-424000-5-396
Net Income-2-64-14-98-41-42-81-47-39-45-44-1421,611-745413-793-425-426-1,256-1,180
Cash Flow ($'000)2014-03-312014-06-302014-09-302014-12-312015-03-312015-06-302015-09-302015-12-312016-03-312016-06-302016-09-302016-12-312017-06-302017-09-302017-12-312018-03-312018-06-302018-09-302018-12-312019-06-302019-09-30
Cash Operating-0-13-195-12-26-11-64-11-2-2-320-217-183-8964-502
Cash Investing0-287-400361650-152
Cash Financing0266-512271064222724832-275752-93533